FY2025 · period end Dec '25 · from the 10-K filed Feb 20, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $8.23B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0001193125-26-288390 | Jun 26, 2026 | Jun 29, 2026 | Jun 29, 2026 20:02 UTC | EDGAR |
| 8-K | 0001193125-26-242207 | May 22, 2026 | May 27, 2026 | May 27, 2026 21:30 UTC | EDGAR |
| 8-K | 0001193125-26-218098 | May 12, 2026 | May 12, 2026 | May 12, 2026 10:30 UTC | EDGAR |
| 10-Q | 0001193125-26-201710 | Mar 31, 2026 | May 1, 2026 | May 1, 2026 21:11 UTC | EDGAR |
| 8-K | 0001193125-26-183430 | Apr 22, 2026 | Apr 28, 2026 | Apr 28, 2026 10:33 UTC | EDGAR |
| 8-K | 0001193125-26-183411 | Apr 28, 2026 | Apr 28, 2026 | Apr 28, 2026 10:30 UTC | EDGAR |
| 10-K | 0001193125-26-059853 | Dec 31, 2025 | Feb 20, 2026 | Feb 19, 2026 23:36 UTC | EDGAR |
| 8-K | 0001193125-26-043620 | Feb 10, 2026 | Feb 10, 2026 | Feb 10, 2026 11:30 UTC | EDGAR |
Direct links to SEC EDGAR. ZBH has additional filings available on the SEC site.
Figures a later SEC filing revised from what was first reported. Each diff compares the same XBRL tag across two filings — both linked, so you can check it yourself.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2020
Major restatementwas-$274.4M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Domestic·FY 2021
Major restatementwas-$275.7M
Revised up in a 8-K.
Income (Loss) from Continuing Operations before Income Taxes, Domestic·FY 2020
Major restatementwas-$592.9M
Revised up in a 10-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·FY 2021
Major restatementwas$418.4M
Revised up in a 8-K.
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest·Q3 2021
Major restatementwas$162.6M
Revised up in a 10-Q.
Revenue from Contract with Customer, Excluding Assessed Tax·Q1 2021
Major restatementwas$1.8B
Revised down in a 10-Q. Any P/S built on the original was 15.4% too low.
ZBH is not the only one.
See every restatement we've found across the market — or get an alert the next time ZBH revises a number.
Restatements are detected by comparing every vintage of a fact across all of ZIMMER BIOMET HOLDINGS, INC.'s filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows ZBH's most significant revisions, and a figure absent from it has not been certified as unrevised.
Who is buying and selling ZIMMER BIOMET HOLDINGS, INC. — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on ZBH yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on ZBH and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $7.39B |
| $6.94B |
| $6.83B |
| Gross Profit | $5.74B | $5.49B | $5.31B | $4.92B | $4.87B |
|---|
| Operating Income | $1.10B | $1.29B | $1.28B | $0.70B | $0.86B |
|---|
| Net Income | $0.71B | $0.90B | $1.02B | $0.23B | $0.40B |
|---|
| EPS (Diluted) | $3.55 | $4.43 | $4.88 | $1.10 | $1.91 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $23.09B | $21.37B | $21.50B | $21.07B | $23.46B |
| Total Liabilities | $10.39B | $8.89B | $9.01B | $9.04B | $10.79B |
| Stockholders' Equity | $12.71B | $12.48B | $12.49B | $12.03B | $12.67B |
| Cash & Equivalents | $0.59B | $0.53B | $0.42B | $0.38B | $0.48B |
| Total Debt | — | — | — | — | $1.98B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $1.70B | $1.50B | $1.58B | — | $1.50B |
| Capital Expenditures | $0.22B | $0.20B | $0.29B | $0.19B | $0.14B |
| Free Cash Flow | $1.47B | $1.30B | $1.29B | — | $1.36B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 69.7% | 71.5% | 71.8% | 70.9% | 71.3% |
| Operating Margin | 0.1% | 0.2% | 0.2% | 0.1% | 0.1% |
| Net Margin | 0.1% | 0.1% | 0.1% | 0.0% | 0.1% |
| Return on Equity | 5.6% | 7.2% | 8.4% | 1.9% | 3.2% |
| Return on Assets | 3.2% | 4.2% | 4.8% | 1.0% | 1.7% |
| Debt / Equity | 0.59× | 0.50× | 0.46× | 0.47× | 0.16× |
